Non-alcoholic Fatty Liver Disease: all 1,507 studies
Page 7 of 16. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.
- Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal ObesityCompletedNCT06377631Not applicable
- MASLD in Primary Hypothyroidism and Efficacy of DapaglifozinActive, not recruitingNCT06373523Early Phase 1
- Screening for Chronic Liver Diseases in General PopulationActive, not recruitingNCT06366425Not applicable
- Dose Escalation Study of Kylo-0603 in Healthy SubjectsCompletedNCT06365580Phase 1
- The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT06357052
- An Imaging-based Quantitative Biomarker Assay for NAFLD in ChildrenActive, not recruitingNCT06354491Not applicable
- Digital Therapeutic Lifestyle Intervention Program for Patients With MASLDWithdrawnNCT06352177Not applicable
- Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 DiabetesCompletedNCT06348706Phase 3
- Motivational Interviewing in the Management of Non Alcoholic Fatty Liver DiseaseCompletedNCT06348628Not applicable
- Digital Pathology and AI for Liver Outcomes in MASLDCompletedNCT06344364
- ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)CompletedNCT06342947Phase 2
- Manual Therapy in Metabolic Liver DiseaseCompletedNCT06338618Not applicable
- The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT06338449Not applicable
- A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH PatientsActive, not recruitingNCT06322628Phase 2
- Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLDCompletedNCT06321211
- DIAbetes and NAFLDActive, not recruitingNCT06315361
- A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)CompletedNCT06309992Phase 3
- Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy FemalesCompletedNCT06308874Phase 1
- Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy MalesCompletedNCT06308861Phase 1
- Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASHCompletedNCT06297434Phase 2
- Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.CompletedNCT06275906Not applicable
- A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT06256926Phase 2
- Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic InflammationCompletedNCT06247137Not applicable
- Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic FactorsCompletedNCT06244550Not applicable
- Direct Versus Indirect Effect of Amino Acids on HepatokinesActive, not recruitingNCT06240039Not applicable
- Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease In Obese Adolescents?CompletedNCT06229184Not applicable
- Non-Invasive Diagnostic Tests for MASLD in Pediatric PopulationActive, not recruitingNCT06218589Not applicable
- Feasibility of Immersive Virtual Reality Dietician Program in Metabolic-dysfunction Associated Steatotic Liver DiseaseCompletedNCT06215131Not applicable
- Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic SteatohepatitisCompletedNCT06195943Not applicable
- A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.CompletedNCT06188026Phase 1
- Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver DiseaseCompletedNCT06176079
- To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .CompletedNCT06168383Phase 2
- A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Active, not recruitingNCT06161571Phase 3
- A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and OverweightActive, not recruitingNCT06151964Phase 1/2
- A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And HyperoxaluriaWithdrawnNCT06138327Phase 1
- Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT06127225Phase 2
- Dexamethasone/Pancreatic Clamp P&FWithdrawnNCT06126354Phase 1
- Non-alcoholic Steatohepatitis Registry Platform StudyTerminatedNCT06123858
- Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in AdultsCompletedNCT06121999Not applicable
- The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes MellitusCompletedNCT06117137Phase 3
- The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver DiseaseActive, not recruitingNCT06113003Early Phase 1
- A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)CompletedNCT06108219Phase 2
- Clinical Effects of New Approach on Patients With Non-alcoholic SteatohepatitisCompletedNCT06105060Early Phase 1
- Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASHCompletedNCT06104319Phase 2
- The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin ACompletedNCT06101433Not applicable
- Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver DiseaseCompletedNCT06097039
- Ultrasound Liver Fat Quantification on Pediatric PatientsCompletedNCT06095479Not applicable
- Probiotic Supplementation IN NAFLD PatientsCompletedNCT06074094Phase 4
- Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASHCompletedNCT06054815Phase 2
- Multi-morbidity Screening in People With Type 2 Diabetes and Pre DiabetesActive, not recruitingNCT06053177
- The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) SubjectsCompletedNCT06044467Phase 1
- Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male SubjectsCompletedNCT06037577Phase 1
- Effect of Vitamin A and Calcium in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT06031532
- Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver DiseaseCompletedNCT06026293
- Impact of FMT on the Phenome in Patients With NAFLD and FibrosisCompletedNCT06024681Not applicable
- A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk FactorCompletedNCT06024408Phase 1
- Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement StudyActive, not recruitingNCT06011356
- Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DMActive, not recruitingNCT06005012Phase 2
- IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)CompletedNCT05989711Phase 2
- Accurate Point of Care Liver Disease DiagnosticsActive, not recruitingNCT05986916
- Phase I Pharmacokinetic Study of HUYPS-1 in Healthy VolunteersCompletedNCT05983328Phase 1
- Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic SteatohepatitisActive, not recruitingNCT05979779Phase 2
- Defining Circadian Metabolism in Non-alcoholic Fatty Liver DiseaseStatus unknownNCT05962099
- Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD).Active, not recruitingNCT05946330Not applicable
- Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)CompletedNCT05946148
- Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)CompletedNCT05935826Phase 3
- Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD SubjectsCompletedNCT05930093Not applicable
- Comparing Effects of Beetroot Juice and Mediterranean Diet on Liver Enzymes and Sonography in Patients With NAFLDCompletedNCT05909631Phase 1
- Interventional Strategy in Tackling Emerging Non-alcoholic Fatty Liver Disease in Childhood ObesityCompletedNCT05905185Phase 4
- Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral LoadCompletedNCT05898841Phase 4
- Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLDCompletedNCT05897606Phase 1
- A Clinical Study to Evaluate the Effect of SIM01 in Female With NAFLDCompletedNCT05885373Not applicable
- A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)CompletedNCT05877547Phase 2
- Effects of Time-restricted Hypocaloric Diet in Patients with NAFLDCompletedNCT05866744Not applicable
- To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver DiseaseCompletedNCT05858138Not applicable
- Quantification of Hepatic Steatosis With Different Ultrasound FrequencyActive, not recruitingNCT05855239
- Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.Status unknownNCT05849220Not applicable
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy ParticipantsCompletedNCT05848440Phase 1
- Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary SyndromeCompletedNCT05843955
- A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionCompletedNCT05835180Phase 1
- FCI Effectiveness in NAFLD StratificationWithdrawnNCT05827432Not applicable
- CM-101 in NASH Patients - The SPLASH StudyCompletedNCT05824156Phase 2
- Semaglutide in Nonalcoholic Fatty Liver DiseaseCompletedNCT05813249Phase 4
- Non-Alcoholic Fatty Liver Disease and Anthropometric MeasurementsCompletedNCT05810506
- A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With FibrosisCompletedNCT05809934Phase 2
- A Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver HealthCompletedNCT05808049Not applicable
- Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal ObesityCompletedNCT05807204Not applicable
- Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study)CompletedNCT05804422Not applicable
- Quantitative Detection Efficiency of UDFF for Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05802199
- Fibrosis Reduction in Non Alcoholic SteatohepatitisActive, not recruitingNCT05798702Not applicable
- Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD）CompletedNCT05795517Phase 2
- Lifestyle Guidance Methods in NAFLDCompletedNCT05792488Not applicable
- Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and SteatosisStatus unknownNCT05786963
- Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLDStatus unknownNCT05784779Phase 1/2
- Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT05768334Phase 3
- A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate FormulationsCompletedNCT05766709Phase 1
- Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-surveyCompletedNCT05765890
- Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT05754385Not applicable
- A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese MenCompletedNCT05742919Phase 1
- Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver DiseaseActive, not recruitingNCT05741957Not applicable